anmelden
FTSE 100
10.241,76
PKT
+8,69
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.11.17 | Shell (ex Royal Dutch Shell) Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.11.17 | BP Neutral | Goldman Sachs Group Inc. | |
| 07.11.17 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 07.11.17 | Shell (ex Royal Dutch Shell) buy | HSBC | |
| 07.11.17 | BP buy | HSBC | |
| 07.11.17 | International Consolidated Airlines Neutral | Goldman Sachs Group Inc. | |
| 06.11.17 | International Consolidated Airlines buy | UBS AG | |
| 06.11.17 | Barclays buy | UBS AG | |
| 06.11.17 | International Consolidated Airlines Neutral | Goldman Sachs Group Inc. | |
| 06.11.17 | GSK Underweight | Morgan Stanley | |
| 06.11.17 | Barclays buy | Deutsche Bank AG | |
| 06.11.17 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 03.11.17 | HSBC Sector Perform | RBC Capital Markets | |
| 03.11.17 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 03.11.17 | Shell (ex Royal Dutch Shell) Hold | Société Générale Group S.A. (SG) | |
| 03.11.17 | easyJet Hold | Deutsche Bank AG | |
| 03.11.17 | International Consolidated Airlines buy | Deutsche Bank AG | |
| 03.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 03.11.17 | BP overweight | JP Morgan Chase & Co. | |
| 03.11.17 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 03.11.17 | Glencore Neutral | JP Morgan Chase & Co. | |
| 02.11.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 02.11.17 | Prudential buy | Citigroup Corp. | |
| 02.11.17 | National Grid neutral | Barclays Capital | |
| 02.11.17 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.11.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.11.17 | BP Hold | Kepler Cheuvreux | |
| 01.11.17 | AstraZeneca buy | Kepler Cheuvreux | |
| 01.11.17 | BP Neutral | Citigroup Corp. | |
| 01.11.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.11.17 | BP buy | Deutsche Bank AG | |
| 01.11.17 | BP buy | UBS AG | |
| 01.11.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.11.17 | Diageo overweight | JP Morgan Chase & Co. | |
| 01.11.17 | BP overweight | JP Morgan Chase & Co. | |
| 01.11.17 | Barclays overweight | JP Morgan Chase & Co. | |
| 01.11.17 | AstraZeneca Reduce | HSBC | |
| 01.11.17 | BP buy | HSBC | |
| 01.11.17 | BP Neutral | Goldman Sachs Group Inc. | |
| 31.10.17 | BP Sector Perform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.